Alexandru Melinte, Irina Strâmbu, Diana Leonte, Mihai Dumitrescu, Cristian Paleru and Ciprian Bolca
present in the lower lobes. However, radiographic images and invasive diagnostic procedures such as percutaneous fineneedle aspiration biopsy or bronchoscopy are considered insufficient for a clear diagnosis. Because of this, the best way of reaching a diagnosis and a therapeutic cure remains through surgery ( 5 , 8 ).
Macroscopically, the most common presentation of inflammatory myofibroblastic tumours appears as wellcircumscribed, non-encapsulated, firm, usually yellow–white masses containing variable inflammation, haemorrhage, calcification, and rarely cavitations
Tatiana Paola Pacheco Páez, German Gutierrez Parra, Alirio Rodrigo Bastidas Goyes, María Daniela Hernández Arcila, Paula Marcela Alcaraz Cañizares, Julio César García Casallas and Daniel Martin Arsanios
initiated. Systemic inflammatory response modulation was observed from the third day of hospitalisation in the ICU. Vasopressor support could be weaned and sedation suspended, and the extubation protocol was started. Bronchoscopy with bronchoalveolar lavage (BAL) was performed with acid fast bacilli and Gram staining, reporting the presence of K. rosea After 5 days, the modulation of the inflammatory response and hemodynamic and respiratory status were achieved.
Kocuria are non-encapsulated, non-endospore-forming Grampositive cocci from the
formation of human synovial cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion. J Anat 185 : 355-67.
Edwards JCW (1995). Consensus statement. Second international meeting on synovium. Cell biology, physiology and pathology. Ann Rheum Dis 54 : 389-91.
Eliaz RE, Szoka FC. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61 : 2592-2601.
Figueiredo F, Jones GM, Thouas GA, Trounson AO. (2002). The eff ect of extracellular
Child 59: 523-527.
Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, Kiely B, Shanahan F, Quigley EM. (2006). Effi cacy of an encapsulated probiotic Bifi dobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101(7): 1581-90.
Wikvall K. (2001). Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 7(2): 201-9.
Williams GM, Kroes R, Munro IC. (2000). Safety evaluation and risk assessment of the herbicide Roundup and its
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Elisabetta de Lutio di Castelguidone, Luigi Camera, Salvatore Tafuto, Antonio Avallone, Andrea Belli, Paola Incollingo, Raffaele Palaia, Francesco Izzo and Antonella Petrillo
manifest as well-defined, hypervascular lesions, owing to their rich capillary network. Non-functioning tumors are larger in size (4 cm) at the time of detection, often well defined, encapsulated and show a heterogeneous enhancement. Rarely, they can be completely cystic, with a hypervascular rim in up to 90% of cases. Malignant tumors often show local invasion into the retroperitoneum and metastases (regional nodes and liver), and they can rarely involve the main pancreatic duct. 22 According to ENETS guideline, PET/CT with 68Ga-labelled somatostatin analogs DOTA
Madelung’s disease also called benign symmetric lipomatosis is a rare disorder of unknown etiology. The disease affects almost exclusively middle-aged men with a history of multi-year alcohol abuse. The major symptom is presence of non-encapsulated benign fat masses, especially in the area of the head and neck. Limited head and neck movement, dysphagia, and dyspnea may appear as well.
The diagnosis is clinical and is supported by imaging methods, often elevated hepatic enzymes in blood serum, and histological examination with finding of mature adipose tissue without signs of proliferation. Therapeutic methods involve liposuction or excision which is a method of choice nowadays.
In this article the authors review current knowledge, research state, and present five cases of the Madelung’s disease occurring within the last 10 years at the Clinic of Otorhinolaryngology and Head and Neck Surgery in Martin, Slovakia.
R. Castaño Zubieta, M. Ruiz, G. Morici, R. Lovera, M. Fernández, J. Caracostantogolo and R. Cavia
): Ecology of New World marsupials. In: Hunsaker II, D. (Ed) The biology of marsupials. New York, USA: Academic Press, pp. 99–113
 Krivokapich, S. J., Pozio, E., Gatti, G. M., Gonzalez Prous, C. L., Ribicich, M., Marucci, G., Rosa, G. L., Confalonieri, V. (2012): Trichinella patagoniensis n. sp. (Nematoda), a new encapsulated species infecting carnivorous mammals in South America. Int. J. Parasitol., 42(10): 903–910. DOI: 10.1016/j.ijpara.2012.07.009 http://dx.doi.org/10.1016/j.ijpara.2012.07.009
 Leiby, D. A
Tiberiu Bratu, Anca Dinu, Mihai Sandesc, Sonia Elena Popovici, Razvan Gabriel Dragoi, Amaricai Elena and Dorel Sandesc
: shape-selective liberation of encapsulated guests. J Am Chem Soc 1995; 117:4417-4418
21. Venkataraman S, Hedrick JL, Ong ZY, et al. The effects of polymeric nanostructure shape on drug delivery. Adv Drug Deliv Rev 2011; 63:1228-1246
22. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm J 2011; 19:129-141
23. Prakash S, Malhotra M, Shao W, Tomaro-Duchesneau C, Abbasi S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer
Anca Dinu, Mihai Sandesc, Sonia Elena Popovici, Razvan Gabriel Dragoi, Amaricai Elena and Tiberiu Bratu
, Grayson SM. Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery. Adv Drug Deliv Rev 2012; 64:852-865
19. Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011; 63: 470-491
20. Jansen JFGA, Meijer EW, de Brabandervan den Berg EMM. The dendritic box: shape-selective liberation of encapsulated guests. J Am Chem Soc 1995; 117:4417-4418
21. Venkataraman S, Hedrick JL, Ong ZY, et al. The effects of polymeric nanostructure shape on drug delivery
. Patients requiring treatment for CLL had increased risk of infection with the highest risks on patients treated with purine analoges or alemtuzumab. Patients treated with ibrutinib had higher risk of infection compared to treatment naive patients.
Patient with CLL are reported to have a propensity to infection with encapsulated bacteria. A Danish study reported on 317 positive blood cultures in 3,822 patients, which occurred at a rate of 15.5 per 1,000 patient-years in treatment naive and 62.3 per 1,000 patient-years in treated patients. The most commonly isolated